These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24642661)

  • 1. KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).
    Casadei Gardini A; Capelli L; Ulivi P; Giannini M; Freier E; Tamberi S; Scarpi E; Passardi A; Zoli W; Ragazzini A; Amadori D; Frassineti GL
    PLoS One; 2014; 9(3):e92071. PubMed ID: 24642661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.
    Guedes JG; Veiga I; Rocha P; Pinto P; Pinto C; Pinheiro M; Peixoto A; Fragoso M; Raimundo A; Ferreira P; Machado M; Sousa N; Lopes P; Araújo A; Macedo J; Alves F; Coutinho C; Henrique R; Santos LL; Teixeira MR
    BMC Cancer; 2013 Apr; 13():169. PubMed ID: 23548132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.
    Janku F; Lee JJ; Tsimberidou AM; Hong DS; Naing A; Falchook GS; Fu S; Luthra R; Garrido-Laguna I; Kurzrock R
    PLoS One; 2011; 6(7):e22769. PubMed ID: 21829508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.
    Schönleben F; Qiu W; Allendorf JD; Chabot JA; Remotti HE; Su GH
    J Gastrointest Surg; 2009 Aug; 13(8):1510-6. PubMed ID: 19440799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS and BRAF mutations in 203 esophageal squamous cell carcinomas: pyrosequencing technology and literature review.
    Shigaki H; Baba Y; Watanabe M; Miyake K; Murata A; Iwagami S; Ishimoto T; Iwatsuki M; Yoshida N; Baba H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S485-91. PubMed ID: 23274581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia.
    Palomba G; Colombino M; Contu A; Massidda B; Baldino G; Pazzola A; Ionta M; Capelli F; Trova V; Sedda T; Sanna G; Tanda F; Budroni M; ; Palmieri G; Cossu A; Contu M; Cuccu A; Farris A; Macciò A; Mameli G; Olmeo N; Ortu S; Petretto E; Pusceddu V; Virdis L
    J Transl Med; 2012 Aug; 10():178. PubMed ID: 22931052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas.
    Myers MB; Banda M; McKim KL; Wang Y; Powell MJ; Parsons BL
    Neoplasia; 2016 Apr; 18(4):253-63. PubMed ID: 27108388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma.
    Gou HF; Li X; Qiu M; Cheng K; Li LH; Dong H; Chen Y; Tang Y; Gao F; Zhao F; Men HT; Ge J; Su JM; Xu F; Bi F; Gao JJ; Liu JY
    PLoS One; 2013; 8(4):e62175. PubMed ID: 23637996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
    Hamza A; Masliah-Planchon J; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Bourneix C; Delaye M; Goéré D; Dartigues P; Samalin E; Hilmi M; Lazartigues J; Girard E; Emile JF; Rigault E; Dangles-Marie V; Rioux-Leclercq N; de la Fouchardière C; Tougeron D; Casadei-Gardini A; Mariani P; Peschaud F; Cacheux W; Lièvre A; Bièche I
    Int J Cancer; 2024 Feb; 154(3):504-515. PubMed ID: 37908048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy.
    Cohen DN; Lawson SK; Shaver AC; Du L; Nguyen HP; He Q; Johnson DB; Lumbang WA; Moody BR; Prescott JL; Chandra PK; Boyd AS; Zwerner JP; Robbins JB; Tyring SK; Rady PL; Chappell JD; Shyr Y; Infante JR; Sosman JA
    Clin Cancer Res; 2015 Jun; 21(11):2624-34. PubMed ID: 25724524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice.
    Walcheck MT; Matkowskyj KA; Turco A; Blaine-Sauer S; Nukaya M; Noel J; Ronnekleiv OK; Ronnekleiv-Kelly SM
    PLoS One; 2021; 16(11):e0259245. PubMed ID: 34735515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.
    Quaye L; Song H; Ramus SJ; Gentry-Maharaj A; Høgdall E; DiCioccio RA; McGuire V; Wu AH; Van Den Berg DJ; Pike MC; Wozniak E; Doherty JA; Rossing MA; Ness RB; Moysich KB; Høgdall C; Blaakaer J; ; Easton DF; Ponder BA; Jacobs IJ; Menon U; Whittemore AS; Krüger-Kjaer S; Pearce CL; Pharoah PD; Gayther SA
    Br J Cancer; 2009 Mar; 100(6):993-1001. PubMed ID: 19240718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and genomic characterisation of a panel of human anal cancer cell lines.
    Guerra GR; Kong JC; Millen RM; Read M; Liu DS; Roth S; Sampurno S; Sia J; Bernardi MP; Chittleborough TJ; Behrenbruch CC; Teh J; Xu H; Haynes NM; Yu J; Lupat R; Hawkes D; Di Costanzo N; Tothill RW; Mitchell C; Ngan SY; Heriot AG; Ramsay RG; Phillips WA
    Cell Death Dis; 2021 Oct; 12(11):959. PubMed ID: 34663790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review.
    Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
    Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOTCH1 and PIK3CA mutation are related to HPV-associated vulvar squamous cell carcinoma.
    Choschzick M; Stergiou C; Gut A; Zoche M; Ross JS; Moch H
    Pathol Res Pract; 2023 Nov; 251():154877. PubMed ID: 37839360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tongue carcinoma infrequently harbor common actionable genetic alterations.
    Tan DS; Wang W; Leong HS; Sew PH; Lau DP; Chong FT; Krisna SS; Lim TK; Iyer NG
    BMC Cancer; 2014 Sep; 14():679. PubMed ID: 25234657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification.
    Trilla-Fuertes L; Ghanem I; Gámez-Pozo A; Maurel J; G-Pastrián L; Mendiola M; Peña C; López-Vacas R; Prado-Vázquez G; López-Camacho E; Zapater-Moros A; Heredia V; Cuatrecasas M; García-Alfonso P; Capdevila J; Conill C; García-Carbonero R; Ramos-Ruiz R; Fortes C; Llorens C; Nanni P; Fresno Vara JÁ; Feliu J
    Mol Cell Proteomics; 2020 Apr; 19(4):690-700. PubMed ID: 32107283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic or Locally Recurrent Anal Squamous Cell Carcinoma (SCAC): Current Clinical Trial Landscape and Novel Approaches.
    Rogers JE; Leung M; Johnson B
    Cancer Manag Res; 2022; 14():2065-2077. PubMed ID: 35761823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared hotspot mutations in oncogenes position dogs as an unparalleled comparative model for precision therapeutics.
    Rodrigues L; Watson J; Feng Y; Lewis B; Harvey G; Post G; Megquier K; White ME; Lambert L; Miller A; Lopes C; Zhao S
    Sci Rep; 2023 Jul; 13(1):10935. PubMed ID: 37414794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS and BRAF mutations in anal carcinoma.
    Serup-Hansen E; Linnemann D; Høgdall E; Geertsen PF; Havsteen H
    APMIS; 2015 Jan; 123(1):53-9. PubMed ID: 25244542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.